Abstract
Salvage radiotherapy after radical prostatectomy can be delivered either in case of biochemical recurrence or in situation of clinical relapse. In this last case, results are poor regarding disease-free survival but quite interesting regarding the local control rate. The best situation for salvage radiotherapy is still the rising PSA case: half of the patients can be in complete remission at 5 years after 65 Gy radiotherapy. The role of hormone therapy combined with salvage radiotherapy is still under investigation.
Publication types
-
Comparative Study
-
English Abstract
-
Review
MeSH terms
-
Antineoplastic Agents, Hormonal / administration & dosage
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Combined Modality Therapy
-
Humans
-
Male
-
Neoplasm Recurrence, Local
-
Patient Selection
-
Prognosis
-
Prostate-Specific Antigen / blood*
-
Prostatectomy*
-
Prostatic Neoplasms / blood
-
Prostatic Neoplasms / drug therapy
-
Prostatic Neoplasms / mortality
-
Prostatic Neoplasms / radiotherapy*
-
Prostatic Neoplasms / surgery*
-
Radiotherapy Dosage
-
Radiotherapy, Adjuvant
-
Randomized Controlled Trials as Topic
-
Salvage Therapy
-
Time Factors
Substances
-
Antineoplastic Agents, Hormonal
-
Prostate-Specific Antigen